Wednesday, October 24, 2018 10:00:59 AM
ENDRA's TAEUS technology, which uses RF energy to enhance ultrasound, is designed to provide information on human tissue composition, function and temperature in ways previously possible only on computed tomography (CT) & magnetic resonance imaging (MRI) – but at a fraction of the cost, and at the point of patient care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over one billion people globally and which has no practical diagnostic tools.
"We look forward to attending these premier industry conferences in November as we prepare for TAEUS' anticipated commercial launch in Europe in 2019," said Francois Michelon, CEO of ENDRA Life Sciences. "Our formal presence at these events will allow us to share the status of our developing TAEUS liver technology, build new clinical relationships and collect valuable feedback from clinical thought leaders in hepatology and radiology," concluded Michelon.
The Liver Meeting 2018 Summit
Date: November 9 - 13, 2018
Location: Moscone Center North and South in San Francisco, California
Host: American Association for the Study of Liver Diseases (AASLD)
ENDRA Booth: #246
Website: https://www.aasld.org/events-professional-development/liver-meeting
During The Liver Meeting® 2018, more than 9,500 hepatologists and hepatology health professionals from around the world will gather in San Francisco, CA to exchange the latest liver disease research, discuss treatment outcomes, and interact with colleagues at the annual, must-attend event in the science and practice of hepatology.
The Interdisciplinary Ultrasound Congress 2018
Date: November 14 - 16, 2018
Location: Congress Center in Basel, Switzerland
Host: The Swiss Society for Ultrasound in Medicine (SSUM)
ENDRA Booth: #240
Website: https://ultraschall2018.ch/
The Interdisciplinary Ultrasound Congress is focused on the development of ultrasound, combining almost all disciplines within human medicine in a unique way. From a formerly small ultrasound family a large user population has developed that is fascinated and inspired by ultrasound and its many different uses beyond obstetrics. Over three days, 1,500 participants from Switzerland, Germany, Austria and elsewhere are expected to present new products and build customer relationships.
RSNA 2018 Annual Meeting
Date: November 25 - 30, 2018
Location: McCormick Place in Chicago, Illinois
Host: Radiological Society of North America (RSNA)
ENDRA Booth: #1153
Website: http://www.rsna.org/Annual-Meeting/
The Radiological Society of North America (RSNA®) is an international society of radiologists, medical physicists and other medical professionals with more than 54,000 members from 136 countries across the globe. RSNA hosts the world's premier radiology forum, drawing approximately 55,000 attendees annually to McCormick Place in Chicago, and publishes two top peer-reviewed journals: Radiology, the highest-impact scientific journal in the field, and RadioGraphics, the only journal dedicated to continuing education in radiology.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. ("ENDRA") (NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA's goal is to bring new capabilities to ultrasound - thereby broadening access to better healthcare. For more information, please visit www.endrainc.com.
Recent NDRA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 09:18:05 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:17:00 PM
- ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 • Business Wire • 05/07/2024 12:00:00 PM
- ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents • Business Wire • 05/02/2024 12:00:00 PM
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • Business Wire • 03/28/2024 08:05:00 PM
- ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 • Business Wire • 03/21/2024 12:00:00 PM
- ENDRA Life Sciences Installs First TAEUS System in the UK • Business Wire • 02/27/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:00:45 PM
- New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System • Business Wire • 02/21/2024 01:00:00 PM
- ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe • Business Wire • 02/14/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 10:07:32 PM
- ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology • Business Wire • 11/29/2023 01:00:00 PM
- ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference • Business Wire • 11/27/2023 01:00:00 PM
- ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update • Business Wire • 11/14/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:02:23 PM
- ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents • Business Wire • 11/08/2023 01:00:00 PM
- ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 • Business Wire • 11/07/2023 09:05:00 PM
- ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023 • Business Wire • 11/06/2023 01:00:00 PM
- Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 • Business Wire • 09/07/2023 12:00:00 PM
- ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA • Business Wire • 08/30/2023 12:00:00 PM
- ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents • Business Wire • 08/23/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:45:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:13:52 PM
- ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update • Business Wire • 08/14/2023 08:05:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM